By KIM BELLARD Earlier this month U.S. dockworkers struck, for the first time in decades. Their union, the International Longshoremen’s Association (ILW), was demanding a 77% pay increase, rejecting an offer of a 50% pay increase from the shipping companies. People worried about the impact on the economy, how it might impact the upcoming election,…
Finding a nursing home for yourself or a parent can be daunting. Many facilities are understaffed and the worker shortages have gotten worse since the start of the pandemic. KFF Health News senior correspondent Jordan Rau shares tips about finding nearby homes, evaluating staffing levels, what to look for when visiting, and more. Find additional…
NIH documents viewed by KFF Health News show a pronounced decline in patients at the 200-bed NIH hospital from February through April
Rehabilitation therapy can be a godsend after hospitalization for a stroke, a fall, an accident, a joint replacement, a severe burn, or a spinal cord injury, among other conditions. Physical, occupational, and speech therapy are offered in a variety of settings, including at hospitals, nursing homes, clinics, and at home. It’s crucial to identify a…
Kernesha Weatherly, D.H.A., vice president of imaging services and provider practice, explains impact of widespread implementation
[Sponsored] Health care professionals can learn more about the top-rated ABA therapy providers in New Hampshire to understand where their patients can get help from industry leaders. The post New Hampshire’s Leading ABA Therapy Centers: A Comparison appeared first on MedCity News.
Republicans are pushing for increased use of high deductible health plans (HDHP). HDHPs have increased over time, from 29% of all employer health plans in 2021 to 33% of all employer health plans in 2025. One country that has successfully used HDHP is Singapore. A 2020 Commonweath Fund Report summarizes 3 components of the Singapore’s…
Labcorp’s addition to the network has become a driver for deploying FHIR data exchange at scale for testing among members
Roche is acquiring Poseida Therapeutics, a biotech developing allogeneic cell therapies for cancers and immunological indications. The two companies have been partners in hematological malignancies since 2022. The post Roche Expands Its Scope in Allogeneic Cell Therapy With $1B Poseida Therapeutics Acquisition appeared first on MedCity News.
Fact sheet examining actions taken by the Trump administration and their impact on global tuberculosis.